Tilray Inc. (TLRY)

29.01
NASDAQ : Health Technology
Prev Close 32.34
Day Low/High 29.00 / 32.17
52 Wk Low/High 28.72 / 300.00
Avg Volume 1.60M
Exchange NASDAQ
Shares Outstanding 80.98M
Market Cap 3.16B
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)
The Future of Cannabis: Edibles & Oil Based Products

The Future of Cannabis: Edibles & Oil Based Products

When it comes to products related to cannabis consumption, a rich universe of options continues to scale up around oils and edibles.

General Motors, Boeing, Worldpay, Caesars and the Fed - 5 Things You Must Know

General Motors, Boeing, Worldpay, Caesars and the Fed - 5 Things You Must Know

U.S. stock futures are mixed on Monday; the Federal Reserve is unlikely to lift interest rates when it meets this week; a meeting between Donald Trump and Chinese President Xi Jinping may be pushed off until June, a report says.

3 Important Earnings Reports I'll Be Watching This Week

3 Important Earnings Reports I'll Be Watching This Week

This quarter is a heavy test for Tilray because of the stock's lofty valuation.

How Tilray Can Pass Its First Major Test of 2019

How Tilray Can Pass Its First Major Test of 2019

Tilray is scheduled to report fourth-quarter results after the closing bell Monday.

Chart of the Day: Vetting the Value of Cannabis Companies

Chart of the Day: Vetting the Value of Cannabis Companies

Assessing Aurora and its peers, strictly on the numbers.

Aurora Cannabis' Is a Beast but the Stock Has Entered a Tricky Area Now

Aurora Cannabis' Is a Beast but the Stock Has Entered a Tricky Area Now

Aurora Cannabis' hiring of deal maker Nelson Peltz opens up a wealth of new possibilities for the Canadian pot company.

Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right

Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right

I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.

Aurora Is an 'Undervalued Company,' Says Jim Cramer

Aurora Is an 'Undervalued Company,' Says Jim Cramer

Jim Cramer discusses Real Money's stock of the day and why he believes that the company is undervalued.

Aurora Cannabis Could Triple in the Months Ahead

Aurora Cannabis Could Triple in the Months Ahead

The price of ACB is moving up today and a fresh look at the charts and indicators seems like a good idea.

Andrew Pucher, Chief Corporate Development Officer, Tilray (Photo: Business Wire)

Andrew Pucher, Chief Corporate Development Officer, Tilray (Photo: Business Wire)

Today, Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announces the expansion of its global senior leadership team with the appointment of Andrew Pucher as Chief Corporate Development Officer.

Cronos Is Too Expensive at Current Levels, BMO Report Says

Cronos Is Too Expensive at Current Levels, BMO Report Says

Cronos is currently trading at 85 times forward EBITDA, more than double the multiple of some of its peers in the cannabis space.

Tilray's Valuation Worries Jefferies in Bearish Initiation

Tilray's Valuation Worries Jefferies in Bearish Initiation

Jefferies initiates Tilray with a underperform rating and a $61 price target.

Melius Research Launches Cannabis Industry Coverage

Melius Research Launches Cannabis Industry Coverage

In its first report on cannabis companies, Melius says prices are high.

Tilray's EU Campus In Portugal Successfully Harvests Medical Cannabis (Photo: Business Wire)

Tilray's EU Campus In Portugal Successfully Harvests Medical Cannabis (Photo: Business Wire)

Tilray, Inc. ("Tilray" or "the Company") (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, today announced that its wholly-owned subsidiary Tilray Portugal Unipessoal Lda.

Three Red Days in a Row

Friday could mark a change in the market's pattern for the first time this year.

Tilray® Closes Transaction Acquiring Manitoba Harvest, The World's Largest Hemp Foods Company

Tilray® Closes Transaction Acquiring Manitoba Harvest, The World's Largest Hemp Foods Company

Tilray, Inc. ("Tilray" or "the Company") (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, is pleased to announce the closing of a previously announced definitive agreement (the "Agreement") in which Tilray has...

Tilray® Closes Transaction Acquiring Manitoba Harvest, The World's Largest Hemp Foods Company

Tilray® Closes Transaction Acquiring Manitoba Harvest, The World's Largest Hemp Foods Company

Tilray, Inc. ("Tilray" or "the Company") (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, is pleased to announce the closing of a previously announced definitive agreement (the "Agreement") in which Tilray has...

Cronos Group Rises Following Bernstein Initiation, Other Pot Stocks Fall

Cronos Group Rises Following Bernstein Initiation, Other Pot Stocks Fall

Jefferies gave five securities buy ratings in a note initiating coverage on the cannabis sector Monday.

Acreage Wants to Be Your All-American Cannabis Company

Acreage Wants to Be Your All-American Cannabis Company

In an industry where Canadian companies have been grabbing the headlines, New York-based Acreage Holdings has methodically built itself into the largest American cannabis firm.

Short-Selling Is Really Hard. Just Ask Citron Research

Short-Selling Is Really Hard. Just Ask Citron Research

Examining the influential short-sellers' big winners and losers provides important insights into trading and investing.

The Shift in Sentiment Continues to Have Me Sidelined

And today the VIX collapsed.

Dow Rises as Fed Says Growth Risks Cause Pause in Rate Hikes

Dow Rises as Fed Says Growth Risks Cause Pause in Rate Hikes

Stocks are higher as Wall Street digests the Federal reserve minutes which explained why the central bank paused its plan to raise rates.

Tilray Scoops Up Hemp-Food Maker Manitoba Harvest

Tilray Scoops Up Hemp-Food Maker Manitoba Harvest

Canadian cannabis company Tilray will pay C$419 million to acquire Manitoba Harvest in an effort to expand into the rapidly expanding North American CBD market.

(Photo: Business Wire)

(Photo: Business Wire)

Tilray, Inc. ("Tilray" or "the Company") (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, today announced it has entered into a definitive agreement (the "Agreement") pursuant to which Tilray will acquire all...

Primer For Overlooked Canadian Pot Stocks

Primer For Overlooked Canadian Pot Stocks

Searching Beyond Canopy Growth, Tilray and Cronos reveals a plethora of investment options with companies such as Valens GroWorks and others.

Tilray® Increases Cannabis Supply With Acquisition Of Natura Naturals Holdings

Tilray® Increases Cannabis Supply With Acquisition Of Natura Naturals Holdings

Tilray, Inc. ("Tilray" or "the Company") (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, is pleased to announce the closing of a previously announced definitive agreement ("the Agreement") to acquire all of...

Tilray To Report Fourth Quarter And Full Fiscal Year 2018 Financial Results On March 18, 2019

Tilray To Report Fourth Quarter And Full Fiscal Year 2018 Financial Results On March 18, 2019

Tilray Inc. (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the fourth quarter and full fiscal year ended December 31, 2018 on Monday, March 18, 2019 after market...

IPO Explosion: Cramer's 'Mad Money' Recap (Wednesday 2/13/19)

IPO Explosion: Cramer's 'Mad Money' Recap (Wednesday 2/13/19)

Jim Cramer sees ripple effects of a storm of IPOs, and is worried about the lack of money coming into the market.

Fitbit, Moderna, Tilray: 'Mad Money' Lightning Round

Fitbit, Moderna, Tilray: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Fitbit, Moderna, Tilray, Exelixis, Maxar Technology, International Paper and more.

S&P 500 Is Testing Resistance, and How to Play Activision: Market Recon

S&P 500 Is Testing Resistance, and How to Play Activision: Market Recon

China trade discussions will continue to be a key driver in Wednesday's market action.

TheStreet Quant Rating: D- (Sell)